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Summary
 
Neisseria gonorrhoeae
 
 (GC) is a human pathogen that adheres to and invades genital surfaces. Al-
though pili are required for the initial adherence, the interaction of GC with epithelial cells is also
promoted by a family of outer membrane proteins, the opacity (Opa) proteins such as OpaA
protein from strain MS11. Studies have demonstrated that the interaction of the OpaA GC
with epithelial cells involves binding to heparan sulfate attached to syndecan receptors. However,
other Opa proteins interact with CEA gene family member 1 (CGM1) or biliary glycoprotein
(BGP), members of the CD66 antigen family. In this study, we demonstrate that, in addition,
the 180-kD carcinoembryonic antigen (CEA) is a receptor for Opa proteins. This conclusion
was based on the following observations. First, transfected HeLa cells expressing CEA (HeLa-
CEA) and the CEA-expressing colon cancer cell line (LS 174T) bound and subsequently en-
gulfed the Opa
 
1
 
 bacteria. These interactions were inhibited by anti-CEA antibody, but could
not be inhibited by addition of heparin. Furthermore, OpaI 
 
E. coli
 
 directly bound purified CEA.
We also compared the adherence and invasion by Opa
 
1
 
 bacteria of CD66 transfected HeLa cells:
HeLa-BGPa, HeLa-CGM6, HeLa-NCA, HeLa-CGM1a, HeLa-CEA, and HeLa-Neo serving
as negative control. Using OpaI as the prototype, the relative ability of the transfected HeLa cell
lines to support adherence was (CEA 
 
5
 
 BGPa 
 
.
 
CGM1a 
 
.
 
NCA 
 
..
 
CGM6 
 
5
 
 Neo). The
ability to mediate invasion of the transfectant cells was (CGM1a 
 
.
 
CEA 
 
.
 
BGPa 
 
.
 
NCA
 
.
 
CGM6 
 
5
 
 Neo). Among the Opa proteins tested, OpaC proved to be bifunctional, able to
mediate adherence to both syndecan receptors and to CD66 antigens.
 
N
 
eisseria gonorrhoeae
 
 (GC)
 
1
 
 cause uncomplicated gonor-
rhea, pelvic inflammatory disease, disseminated gono-
coccal infection, and ophthalmia neonatorum. These
diseases result from the ability of GC to adhere to and pen-
etrate mucosal epithelial cells (1, 2). Pili are the compo-
nents promoting the initial adherence and infection by GC
(3–5).
Pathobiological studies of gonococcal infection are ham-
pered by the highly restricted species specificity of gonor-
rheal disease so that there is no good animal model available
currently. The most informative model has been in vitro in-
fection of human fallopian tube organ culture (FTOC; 6,
7). Initial attachment of GC to FTOC mucosal columnar
epithelial cells is mediated by pili. About 18 h after infec-
tion, the attached organisms are endocytosed by the non-
ciliated cell. Phagocytosed GC appear to be rapidly transcy-
tosed through the epithelial cells and enter the submucosal
space at the base of the cells (8). Expression of a family of
outer membrane proteins, the phase-variable opacity (Opa)
proteins, by GC enhances their ability to adhere and to in-
vade the epithelial cells in FTOC (9). Moreover, Opa ex-
pressing 
 
Escherichia coli
 
 can attach and invade human fallo-
pian tube epithelium at low levels (10). These results
indicate that Opa proteins alone may be sufficient to pro-
mote adherence to and invasion of the human cells. Studies
with infected human volunteers have demonstrated a strong
selection for Opa
 
1
 
 gonococci among the reisolates suggest-
ing that Opa proteins play a role in gonococcal pathogene-
sis (11, 12).
Identification of the receptors involved in the interaction
with host cells is a crucial step in understanding disease cau-
sation by bacteria. Some components on the mammalian
cell surface have been shown to act as receptors for patho-
genic microorganisms. One of the best defined receptor–
ligand relationships is the interaction of 
 
Yersinia pseudotuber-
culosis
 
 invasin with 
 
b
 
1 chain integrins on the mammalian
cell surface (13). E-cadherin has recently been demon-
strated as the receptor for internalin, a surface protein for
 
1
 
Abbreviations used in this paper:
 
 BGP, biliary glycoprotein; CEA, carcino-
embryonic antigen; CGM, CEA gene family member; CHO, Chinese
hamster ovary; FTOC, fallopian tube organ culture; GC, 
 
Neisseria gonor-
rhoeae
 
; NCA, nonspecific cross-reacting antigens; Opa, opacity.
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entry of 
 
Listeria monocytogenes
 
 into epithelial cells (14). In
GC, a variety of components participate in the interaction
with the eukaryotic cells. These include pili (3), LPS (15), a
36-kD glycolipid-binding adhesin (16), interaction with
carbohydrate structures on epithelial cells (17), and the Opa
proteins (18). In gonococcal strain MS11, the Opa protein
family consists of 11 unlinked 
 
opa
 
 genes whose sequences
are known (19). One distinct Opa protein, the OpaA, has
been correlated with adherence and subsequent internaliza-
tion of GC by Chang conjunctival cells (20–22). The other
members of Opa family are able to stimulate PMN adher-
ence and phagocytosis (22, 23). It has been demonstrated
that the interaction of the OpaA GC with epithelial cells
involves binding to heparan sulfate syndecan receptors that
are situated on the cell surface (24, 25). Moreover, recent
studies indicated that gene family member (CGM)1 (26)
and biliary glycoprotein (BGP) (27), members of the carci-
noembryonic antigen (CEA) or CD66 family, serve as re-
ceptors for Opa
 
1
 
 bacteria for promoting adherence and in-
ternalization. In the instance of BGP or CD66a, it has been
shown that the portion of the molecule that interacted with
the Opa protein is the NH
 
2
 
-terminal domain that is ho-
mologous to the IgG variable domain (IgV-like; 28). This
is supported by the ability of CGM1 to interact with Opa
proteins since its surface-exposed portion consists solely of
one IgV-like domain (26).
However, in addition to CD66a (BGP) and CD66d
(CGM1), the CEA family also includes CD66b (CGM6),
CD66c (NCA), and CD66e, the classical tumor associated
CEA. We have investigated the activity of the different
CD66 antigens with Opa proteins by expressing these five
members of the CD66 family in HeLa cells and demon-
strated that the transfectants differ in their ability to support
adherence and internalization. Finally, OpaC protein from
MS11 demonstrated a dual function; it interacted with
both heparan sulfate syndecan receptors and members of
the CEA family.
 
Materials and Methods
 
Bacterial Strains, Monoclonal Antibodies, and Cell Lines.
 
GC strain
MS11 was cultured and maintained as previously described (29).
Only pilus
 
2
 
 GC and LOS
 
b
 
 (lacto-
 
N
 
-neotetraose) phenotype were
used (30). Recombinant 
 
opa
 
 genes from GC MS11 were constructed
and expressed in 
 
E. coli
 
 HB101 as described previously (23). The
designations of Opa proteins of both GC and 
 
E. coli
 
 are based on
papers of Swanson et al. (11) and Belland et al. (23). 
 
E. coli
 
 HB101
containing the vector pGEM-3Z is designated as pGEM. 
 
E. coli
 
HB101 expressing OpaA, OpaB, OpaC, OpaH, and OpaI genes are
designated as pEXA, pEXB, pEXC, pEXH, and pEXI, respec-
tively. Bacterial suspensions were from Luria-Bertani plates con-
taining 50 
 
m
 
g/ml carbenicillin after growth for 16–20 h at 37
 
8
 
C.
COL-1 mAb, specific for CGM1 and CEA only, was donated by
Z. Shi (Zymed Laboratories Inc., San Francisco, CA) and mAb
IB4 reactive with CD18 was provided by S. Wright (Merck Inc.,
Rahway, NJ).
The human colon adenocarcinoma cell line LS 174T was pur-
chased from American Type Culture Collection (Rockville,
MD). HeLa-CEA, HeLa-CGM1a, HeLa-BGPa, HeLa-NCA,
and HeLa-CGM6 cells were constructed by transfecting HeLa
cells with CEA, CGM1a, BGPa, NCA, and CGM6 cDNAs, and
selected for surface antigen expression (31). HeLa-Neo cells are
HeLa cells that were transfected with neomycin-resistance gene
only (31).
Wild-type Chinese hamster ovary (CHO)-K1 and isogenic
mutants 745 and 677 that have specific defects in proteoglycan
biosynthesis were provided by J.D. Esko (University of Alabama,
Birmingham, AL) (32–34). Mutant CHO cell 745 lacks xylosyl-
transferase and expresses no heparan sulfate and chondroitin sul-
fate, while mutant 677 which has defective 
 
N
 
-acetylglucosaminyl
and glucoronosyltransferases, produces no heparan sulfate, but
2–3 times increased chondroitin sulfate.
 
Adherence and Internalization Assays.
 
All cell lines were cul-
tured in RPMI 1640 medium (GIBCO BRL, Gaithersburg, MD)
with 10% FCS (Hyclone Labs., Logan, UT). For adherence as-
says, cells were grown to confluence (1–2 
 
3
 
 10
 
5
 
 cells/well) in
24-well culture plates (Falcon, Lincoln Park, NJ), and washed
twice with serum-free RPMI. 
 
E. coli
 
 were suspended in RPMI at
OD
 
540
 
 of 0.04, and 0.5 ml of the bacterial suspensions was added
to each well. The plates were incubated at 37
 
8
 
C with 5% CO
 
2
 
 for
4 h. The incubation period was limited to 2 h when mAb were in-
cluded to avoid their inactivation. Experiments were terminated
by washing three times with 1 ml of serum-free RPMI. Adherent
bacteria were counted by suspending the cells in PBS containing
0.5% saponin (Calbiochem Corp., La Jolla, CA) and plating dilu-
tions on Luria-Bertani agar medium containing 50 
 
m
 
g/ml of car-
benicillin or on GC plates. The level of adherence of GC and 
 
E.
coli
 
 to cells was calculated by determining the CFU associated
with the host cell monolayers. Internalization assays were done in
a similar fashion to adherence assays, but after the period of bacte-
rial interaction to cell lines, the monolayers were washed twice
and then incubated for 90 min with 1.5 ml of RPMI supple-
mented with 100 
 
m
 
g/ml gentamicin (GIBCO BRL). For adher-
ence inhibition assays, the bacteria were added as a suspension in
RPMI containing heparin at 30 
 
m
 
g/ml or 25 
 
m
 
g/ml mAb. The
experiments were performed in duplicate or triplicate.
 
Binding of CEA to OpaI E. coli.
 
pGEM or pEXI were sus-
pended in 1 ml of serum-free RPMI at OD
 
540
 
 of 0.8. 4 
 
m
 
g of pu-
rified CEA antigen (Calbiochem Corp.) was added to each bacterial
suspension and incubated at room temperature for 60 min with
gentle shaking. The bacteria were pelleted and washed once with
RPMI and subjected to SDS-PAGE. The CEA bound to the
bacteria was detected by Western blotting with COL-1 mAb af-
ter electrophoretic transfer to Immobilon-P membrane (Millipore
Corp., Bedford, MA) (35). The bound COL-1 mAb was de-
tected with HRP-conjugated protein A by chemiluminescence
(Amersham Life Science, Arlington Heights, IL).
 
Results
 
Adherence and Invasion of Opa
 
1
 
 Bacteria into HeLa-CD66
Transfectants.
 
The HeLa-Neo, HeLa-BGPa (CD66a), HeLa-
CGM6 (CD66b), HeLa-NCA (CD66c), HeLa-CGM1a
(CD66d), and HeLa-CEA (CD66e) were examined for their
ability to support adherence and invasion of OpaI bacteria.
The internalization of Opa
 
1
 
 bacteria into HeLa-CD66
transfectants was measured by gentamicin killing assay and
the results were confirmed by electron microscopy. pEXI
adhered poorly to HeLa-Neo and CGM6, but attached
very well to HeLa-CEA and HeLa-BGP (Fig. 1 
 
A
 
). The 
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adherence of pEXI to HeLa-CGM1a and HeLa-NCA was
intermediate.
The ability of these cell lines to promote invasion
showed a different pattern. Although the adherence of pEXI
to HeLa-BGPa was high, invasion was limited (Fig. 1 
 
B
 
).
Electron microscopy demonstrated that HeLa-CEA cells were
also able to engulf pEXI (Fig. 1 
 
B
 
) and OpaI GC (Fig. 2).
However, compared to HeLa-CGM1a (Fig. 1 
 
B
 
, 2E), HeLa-
CEA cells demonstrated lower ability to internalize pEXI
or OpaI GC (Figs. 1 
 
B
 
 and 2 
 
B
 
). Virtually all HeLa-
CGM1a cells contained large numbers of GC, but a lower
degree of cellular invasion by OpaI bacteria was observed
with HeLa-CEA cells. HeLa-NCA and HeLa-CGM6 were
hardly invaded at all.
 
OpaI E. coli Bind the CEA Antigen.
 
The HeLa-CEA cells
supported the highest level of adherence with pEXI (Fig. 1
 
A
 
), indicating that the CEA protein is a receptor for Opa
protein. To demonstrate a direct binding of Opa
 
1
 
 bacteria
with CEA, purified CEA was mixed with equal amounts of
Opa negative pGEM or positive pEXI bacteria. The bacte-
ria–CEA mixture was incubated for 1 h, pelleted, and solu-
bilized. The amount of CEA antigen bound to the bacteria
was detected with COL-1 antibody by Western blotting.
As seen in Fig. 3, pEXI bound much more CEA than
pGEM.
 
Multiple Opa Proteins Interact with HeLa-CEA Cells, and
Are Inhibited by Anti-CEA Antibody.
 
Since strain MS11 can
express several Opa proteins, we examined whether other
Opa proteins possess the same function, as illustrated in Fig.
4 
 
A.
 
 HeLa-CEA cells also bound OpaA, OpaB, OpaC, and
OpaH 
 
E. coli
 
 with similar efficiency, but only OpaA-medi-
ated adherence was strongly inhibited by soluble heparin.
Figure 1. Adherence and in-
ternalization of pEXI by HeLa
cells transfected with various
CD66 antigens. All the cell lines
were grown to confluence in 24-
well culture plates containing
RPMI medium 1640 and were
incubated with pEXI for 4.5 h.
The adherent and intracellular E.
coli were distinguished by incu-
bation with gentamicin. (A)
The ability of these cell lines to
bind pEXI: HeLa-CEA .HeLa-
BGP  .HeLa-CGM1a  .NCA
..HeLa-CGM6 5 HeLa-Neo
5 0. (B) The number of intrac-
ellular bacteria. Although HeLa-
CGM1a showed the highest
internalization of pEXI, HeLa-
CEA could also engulf pEXI. The
internalization of pEXI into HeLa-
BGP was negligible. Bars, SEM.
Figure 2. Electron micrographs of internalization of OpaI E. coli and
GC by HeLa-CEA and LS 174T. The micrographs demonstrate the abil-
ity of HeLa-CEA to internalize OpaI E. coli (A) and OpaI GC (B). CEA-
expressing colon cancer cells (LS 174T) were also able to engulf OpaI E.
coli ( C ) and OpaI GC (D). The engulfment of OpaI CG by HeLa-
CGM1a (E) served as a positive control. Bar, 1 mm. 
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The adherence mediated by OpaI and OpaC was inhibited
by anti-CEA antibody (COL-1), but not by IB4 directed
to CD18 antigen (Fig. 4 
 
B
 
). These results demonstrate that
CEA antigen serves as receptor for several Opa proteins.
 
OpaI Bacteria Bind HeLa-CEA and CEA-expressing Colon
Cancer Cells in a Heparin-independent Manner.
 
To further sub-
stantiate that the binding of Opa
 
1
 
 GC with CEA is due to
ligand–receptor interaction, we compared the well-charac-
terized CEA-expressing colon cancer cell line LS 174T
with HeLa-CEA in adhesion assays. As seen in Fig. 5 both
HeLa-CEA and LS 174T bound the OpaI GC in a heparin-
independent fashion, in sharp contrast to the OpaA-medi-
ated interaction. The colon cancer cell line supported ad-
herence about threefold less efficiently than HeLa-CEA,
but the overall pattern was identical.
 
OpaC Bacteria Interact with Both Heparan Sulfate and Members
of the CEA Family.
 
Previously published studies demon-
strated that OpaA-mediated adherence to Chang conjunctival
and CHO cells is dependent on binding to heparan sulfate
syndecan receptors (24, 25). These studies also showed that
OpaC had this activity, and that OpaC GC were able to
bind tritiated heparin. However, the data shown in Fig. 4, 
 
A
 
and 
 
B
 
 indicated that pEXC was able to bind the HeLa-
CEA, and that this binding was inhibited by treatment with
CD66 antibody, suggesting that OpaC was able to mediate
both adherence to syndecans and CD66 antigens. To pro-
vide further evidence that OpaC-mediated adherence to
CHO epithelial cells is heparan sulfate dependent, we exam-
ined the adherence to heparan sulfate-deficient CHO mu-
tants 745 and 677. Compared to wild-type CHO-K1,
OpaC GC adhered to mutant 745 and 677 at a very low
level (Fig. 6 
 
A
 
). Further proof for reactivity with CD66 an-
tigens is provided in Fig. 6 
 
B
 
 showing that pEXC, but not
pEXA, is internalized by HeLa-CGM1a.
 
Discussion
 
GC isolated either from the male urethra or from the
cervix of infected females are most often Opa
 
1
 
 GC (36–38).
Swanson et al. infected male volunteers intraurethrally with
an Opa
 
2
 
 strain of GC, and found that isolates recovered
from the infection were predominantly Opa
 
1
 
 (11). Similar
findings were also obtained with different challenge strains
in further volunteer studies (12). Furthermore, high levels
of Opa-specific antibody after gonococcal infection have been
reported (39). Taken together, these data strongly suggest
in vivo expression of Opa proteins plays an important role
in gonococcal pathogenesis.
The present studies demonstrate that one of the mecha-
nisms for Opa protein-mediated adherence was binding to
CEA and CEA-related proteins. To provide this evidence,
we chose to use a highly defined system, namely the use of
E. coli expressing recombinant Opa proteins and a single
cell line, HeLa transfected with various CD66 antigens.
This strategy circumvents the unavoidable tendency of GC
to alter their Opa phenotype by antigenic variation and al-
lows certainty that the observed effects are strictly attribut-
able to the expression of specific Opa proteins. To confirm
that the results were reflective of gonococcal pathogenesis,
we included experiments using Opa1 GC and also ex-
tended them to a well-characterized CEA-expressing colon
cancer cell line, LS 174T. The CEA HeLa cell transfectants
(HeLa-CEA) and the CEA-expressing colon cancer cell
line bound and engulfed Opa1 bacteria and this interaction
Figure 3. The binding of pu-
rified CEA to pEXI. Equal num-
bers of pGEM (Opa2) and pEXI
(OpaI) were suspended in RPMI
containing equal amounts of
CEA. After incubation, the bac-
teria were recovered by centrifu-
gation, washed, and lysed, and
the lysates were subjected to
SDS-PAGE and transfered to
Immobilon-P membrane. The
CEA bound on the bacteria was
detected by anti-CD66 mAb
(COL-1). Much more CEA was
bound by pEXI than by pGEM.
Figure 4. Multiple Opa pro-
teins promote adherence to
HeLa-CEA. pGEM, pEXA,
pEXB, pEXC, pEXH, and pEXI
were incubated with HeLa-
CEA (A) for 4 h. All of Opa1 E.
coli adhered to the cell lines. (B)
Addition of COL-1 antibody
(CD66) inhibited adherence of
OpaI and OpaC E. coli to HeLa-
CEA. Control antibody IB4
(CD18) had no effect when
added at the same final concen-
tration (25 mg/ml). The interac-
tion of pEXI and pEXC with
HeLa-CEA was for 2 h and only
accounted for the lower bacterial
counts.1561 Chen et al.
was inhibited by anti-CEA mAb. In addition, OpaI E. coli
bound purified CEA antigen more effectively than Opa2
E. coli.
CEA, a 180-kD tumor-associated cell-surface glycopro-
tein, was first described in 1965 (40). Later, it was found
that antibodies to CEA reacted at low level with normal
cells. Also, a number of closely related, cross-reacting anti-
gens were identified that were initially termed nonspecific
cross-reacting antigens (NCA; 41–43). The gene encoding
CEA is located on human chromosome 19 (44), and is a
member of a family of .20 expressible closely related genes
(45) that belong to the Ig gene superfamily (46). The hu-
man CEA family consists of CEA, NCA, BGP (47),
CGM1 including splicing variants CGM1a, CGM1b, and
CGM1c (31, 48), CGM2, CGM6, CGM7, and pregnancy-
specific glycoproteins (49–51). Although the in vivo func-
tion of CEA has not been determined, evidence shows that
CEA functions as an intercellular adhesion molecule (52–
54). The binding of CEA to E. coli has been reported (55–
57), and CEA may also play a role as an accessory molecule
in binding tumor cells to collagen type I (58).
We investigated the relative ability of the individual
CD66 antigens to mediate adherence and internalization of
Opa1 bacteria using HeLa cell transfectant cell lines. HeLa-
CEA and HeLa-BGPa showed the highest level of adher-
ence to OpaI, but BGP internalized the bacteria poorly.
On the other hand, HeLa-CGM1a and HeLa-NCA showed
intermediate levels of adherence, and only CGM1a pro-
moted aggressive phagocytosis of OpaI E. coli (26) and GC
(Fig. 2 E). HeLa-CGM6 (CD66b) could neither bind or
engulf Opa1 bacteria (Fig. 1 A), although CGM6 is highly
expressed on this HeLa cell line (59). Since CEA is not ex-
pressed in neutrophils (60), the most likely candidate for
promoting phagocytosis of Opa1 bacteria is CGM1a. These
results indicated that CD66 family showed variable ability
in promoting adherence and internalization of Opa1 bacte-
ria although they share homology in their NH2 termini (60).
The mechanism of CGM1a-promoted internalization
may be that in CGM1a there is a cytoplasmic domain con-
taining the YLYL motif, termed the immunoreceptor ty-
rosine activation motif, which is found in several receptor
subunits that associate with cytoplasmic tyrosine kinases
(61, 62). Activation of this motif leads to actin polymeriza-
tion and phagocytosis (for review see reference 63). BGPa,
which does not promote internalization of bacteria, does
not contain immunoreceptor tyrosine activation motif in its
cytoplasmic domain, but rather, two copies of immunore-
ceptor tyrosine inhibitory motif that are separated by 26
Figure 5. The interaction of
Opa1 GC with HeLa-CEA cells
and CEA-expressing colon can-
cer cells LS 174T. Opa1 GC
were incubated with HeLa-
CEA (A) in RPMI medium
1640 buffer with or without sol-
uble heparin (30 mg/ml). OpaA
and OpaI promoted adherence
to HeLa-CEA, and OpaA-medi-
ated adherence was inhibited by
heparin. Similar results were ob-
served with CEA-expressing co-
lon cancer line LS 174T.
Figure 6. Binding specificity of
OpaC bacteria for both heparan
sulfate and CD66 receptors. OpaC
GC were incubated with wild-type
CHO-K1 cells and the isogenic
mutants 745 and 677 lacking sur-
face heparan sulfate. OpaC GC ad-
hered to CHO-K1 cells, but not
the 745 and 677 mutants (A). (B)
pGEM, pEXA, and pEXC were in-
cubated with HeLa-CGM1a cells in
RPMI 1640 medium for 4.5 h. The
adherent and intracellular E. coli
were distinguished by incubation
with gentamicin. Only pEXC was
recovered in large numbers after
gentamicin treatment, although both
pEXA and pEXC adhered to the
HeLa-CGM1a.1562 CD66 Antigens, Receptors for Opa Proteins
amino acids (47). This motif has been found in a number of
immunoreceptors that mediate inhibitory effects (64, 65).
However, CEA found on LS 174T cells is anchored to the
membrane through a glycosyl-phosphatidylinositol anchor
(66, 67). The GPI-anchored proteins mediate many func-
tions in cell growth and cell–cell communication, and can
initiate signal transduction (68–70). Thus, it is possible that
the phagocytosis of Opa1 bacteria by means of CGM1a in
neutrophils and CEA in epithelial cells uses the two distinct
signaling mechanisms.
Among the Opa proteins tested, only OpaA showed no
reactivity with CEA or CGM1a. OpaA has previously been
shown to be reactive with heparan sulfate borne by synde-
cans and to bind radioactive heparin (24, 25). These studies
showed that OpaC also had this specificity. Thus, the ques-
tion of whether OpaC protein can interact with both hepa-
ran sulfate syndecan receptors and members of the CEA
family arose. The data shown in Fig. 6 A demonstrates that
OpaC GC bound to normal CHO cells, but failed to bind
to CHO mutant cells defective in heparan sulfate synthesis,
which was further proof for this specificity. On the other
hand, OpaC promoted heparin-independent adherence to
HeLa-CEA cells (Fig. 4 A), and induced the phagocytosis
of OpaC E. coli into HeLa-CGM1a (Fig. 6 B). Thus, MS11
OpaC protein appears to target the two distinct receptors.
Gonorrhea is a genital disease that affects exclusively hu-
man beings, and adherence and invasion of epithelial cells is
one of the important steps in this disease, as well as bacterial
infections in general (71). However, the factors determin-
ing the efficient adherence and internalization of GC with
or into specific cells are still poorly understood and are very
dependent on the specific tissue culture cell line used (72).
Identification of CEA and BGP as a receptor for Opa pro-
teins is an important step in our understanding of GC patho-
genesis. Normal adult human colon epithelium is known
to produce small amounts of CEA-like antigens (73). GC,
when isolated from rectal infections, express Opa proteins
(38). It has also been shown that BGP is expressed on nor-
mal epithelia located in many organs including the uterus,
cervix, prostate, and colon (74). Thus, it is likely that most
of the tissues susceptible to GC infection express one or an-
other member of the CD66 antigen family.
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